Volume 21, Issue 2, Pages (August 2004)

Slides:



Advertisements
Similar presentations
Volume 33, Issue 2, Pages (August 2010)
Advertisements

Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Volume 31, Issue 4, Pages (October 2009)
Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4+ T Cells after Allogeneic Stem Cell Transplantation 
Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Following the Development of a CD4 T Cell Response In Vivo
Volume 29, Issue 6, Pages (December 2008)
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation  Lucrezia Colonna, Mareike.
Volume 31, Issue 5, Pages (November 2009)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 38, Issue 3, Pages (March 2013)
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor  Julien C. Marie,
Volume 28, Issue 1, Pages (January 2008)
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Subsets of Nonclonal Neighboring CD4+ T Cells Specifically Regulate the Frequency of Individual Antigen-Reactive T Cells  Nevil J. Singh, Jennifer K.
Designing and Maintaining the Mature TCR Repertoire
Christine V. Ichim, Džana D
Volume 33, Issue 2, Pages (August 2010)
Selection of a Broad Repertoire of CD4+ T Cells in H-2Ma0/0 Mice
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Acquisition of a Functional T Cell Receptor during T Lymphocyte Development Is Enforced by HEB and E2A Transcription Factors  Mary Elizabeth Jones, Yuan.
Volume 29, Issue 6, Pages (December 2008)
Volume 21, Issue 3, Pages (September 2004)
Volume 15, Issue 9, Pages (May 2016)
Volume 36, Issue 1, Pages (January 2012)
Peter A. Savage, Mark M. Davis  Immunity 
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 31, Issue 5, Pages (November 2009)
Volume 29, Issue 1, Pages (July 2008)
Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and Retention  Nu.
Volume 134, Issue 4, Pages (April 2008)
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 29, Issue 6, Pages (December 2008)
Volume 21, Issue 1, Pages (July 2004)
Volume 11, Issue 2, Pages (August 1999)
Volume 23, Issue 4, Pages (October 2005)
Volume 27, Issue 3, Pages (September 2007)
Positive Selection of Dendritic Epidermal γδ T Cell Precursors in the Fetal Thymus Determines Expression of Skin-Homing Receptors  Na Xiong, Chuhlo Kang,
Volume 43, Issue 5, Pages (November 2015)
Volume 41, Issue 3, Pages (September 2014)
Identification of a T Lineage-Committed Progenitor in Adult Blood
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Volume 37, Issue 3, Pages (September 2012)
Cécile Bouneaud, Philippe Kourilsky, Philippe Bousso  Immunity 
Volume 41, Issue 4, Pages (October 2014)
Volume 42, Issue 1, Pages (January 2015)
Volume 35, Issue 4, Pages (October 2011)
The Shaping of the T Cell Repertoire
Volume 44, Issue 5, Pages (May 2016)
Volume 43, Issue 5, Pages (November 2015)
Volume 29, Issue 5, Pages (November 2008)
Volume 29, Issue 4, Pages (October 2008)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 2, Issue 1, Pages (January 2008)
Myung H. Kim, Elizabeth J. Taparowsky, Chang H. Kim  Immunity 
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Volume 126, Issue 6, Pages (September 2006)
Volume 41, Issue 4, Pages (October 2014)
Volume 7, Issue 2, Pages (August 1997)
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 28, Issue 5, Pages (May 2008)
Volume 31, Issue 6, Pages (December 2009)
Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution  Maria Gendelman, Maryam Yassai,
Volume 31, Issue 6, Pages (December 2009)
Volume 7, Issue 1, Pages (July 2010)
Volume 9, Issue 2, Pages (August 1998)
Volume 23, Issue 4, Pages (October 2005)
B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Generation of Functional Thymocytes in the Human Adult
Presentation transcript:

Volume 21, Issue 2, Pages 267-277 (August 2004) Recognition of the Peripheral Self by Naturally Arising CD25+ CD4+ T Cell Receptors  Chyi-Song Hsieh, Yuqiong Liang, Aaron J. Tyznik, Steven G. Self, Denny Liggitt, Alexander Y. Rudensky  Immunity  Volume 21, Issue 2, Pages 267-277 (August 2004) DOI: 10.1016/j.immuni.2004.07.009

Figure 1 Experimental Strategy TCRβ transgenic mice develop naturally arising CD25+ CD4+ T cells that are anergic/hypoproliferative and suppressive upon TCR ligation. Because the TCRβ chain is fixed, the TCR repertoire can be analyzed by cloning and sequencing only the endogenously rearranged TCRα genes from CD25+ or CD25− CD4+ TCli TCRβ transgenic T cells. As the mice are on a TCRα+/− background, only one TCR is expressed per T cell. TCRα genes can then be retrovirally expressed in CD25− CD4+ αβ-TCR transgenic × RAG1−/− T cells, recreating the original TCR. TCR signaling in the recipient CD25− T cell should result in conventional T cells responses such as proliferation, irrespective of the origin of the transferred TCR. Immunity 2004 21, 267-277DOI: (10.1016/j.immuni.2004.07.009)

Figure 2 The TR TRAV14:TCli-β TCR Repertoire Only Partially Overlaps with the CD25− CD4+ Repertoire TRAV14 TCRα genes were isolated by RT-PCR from CD25+ and CD25− T cells purified from two TCli-TCRβ × TCRα+/− mice as described in the Experimental Procedures on two different occasions to generate two independently derived CD25+ and CD25− TCRα libraries. TCRα gene sequences were analyzed by IMGT-V-QUEST. (A) TRAV14-subtype and J region usage by CD25+ and CD25− T cells. Data shown are for V subtypes and J regions with a greater than 5% and 2% frequency, respectively. Results of two independent experiments are shown. ND (not determined) refers to sequences for which IMGT did not identify a TRAJ region. (B) CDR3 length distribution as determined by IMGT-V-QUEST. (C) Similarity Index analysis suggests that the TR and CD25− TCR repertoires overlap by less than ∼25%. The Jaccard index is an estimate of the similarity between two sample sets (Cj = number of common species/number of total species observed). The number of occurrences of each sampled species is not considered. For this purpose, an individual TCR species is defined by its unique CDR3 amino acid sequence. By comparing the first half of each CDR3 sequence sample set with the second half, we obtained an empiric index value for sample sets that should be identical (∼0.15). We then compared the first half of each set with the first half of other sets, as well as the second half with the second half. The average Jaccard index of ∼0.025 between CD25+ and CD25− sets isolated at the same time, in combination with data from the Morisita-Horn index calculations (Supplemental Figure S1), suggests that the TR and CD25− TCR repertoires overlap semiquantitatively by <25%. Jaccard and Morisita-Horn indexes were calculated using the statistical package EstimateS (Colwell, 1997). Immunity 2004 21, 267-277DOI: (10.1016/j.immuni.2004.07.009)

Figure 3 TR TCRs Are Self-Reactive: Acquisition of TR TCRs Results in Rapid In Vivo Expansion and Wasting Disease TCli αβ-TCR × RAG1-deficient CD4+ T cells were retrovirally transduced with MigR1 “empty” vector or with TRAV14 TCRα libraries derived from CD25+ or CD25− CD4+ T cells. Three days after in vitro activation, 106 T cells were adoptively transferred into TCRα-deficient hosts by intravenous injection. Transduction efficiency was approximately 1% for all conditions in this experiment. (A) Expansion of TCRα-transduced T cells. The relative expansion of transduced T cells was assessed as the percentage of Vα2+ or GFP+ cells within the adoptively transferred Vβ6+ T cell population in the peripheral blood and the spleen at the times indicated (top). The size of the adoptively transferred population is also shown as the percentage of Vβ6+ T cells in the peripheral blood or spleen (middle). Last, the absolute numbers of transduced T cells residing in the spleen are calculated based on flow cytometric analysis (bottom). Each point represents data from an individual mouse (“empty” vector n = 4, CD25+ n = 7, CD25− n = 6), with half of the group harvested at 5 or 9 weeks. (B) Expansion of T cells expressing CD25+ TCRα chains causes wasting disease. The ratio of the starting weight of recipient mice is shown ± SEM (“empty” vector n = 2, CD25+ n = 4, CD25− n = 3). Weight loss was associated with gross pathologic findings of colon inflammation, including bowel wall thickening, poorly formed stool, and shortening of the colon (data not shown). Immunity 2004 21, 267-277DOI: (10.1016/j.immuni.2004.07.009)

Figure 4 A Pool of 10 TR TCRs Recognize Peripherally Presented Self Antigen:MHC Class II Complexes with Higher Avidity than 10 CD25− TCRs (A) Analysis of a pool of 10 CD25+ or CD25− TCRα chains (Supplemental Table S1) shared between both independently derived CD25+ TCRα libraries or both CD25− TCRα libraries, respectively. TCli αβ-TCR × RAG1-deficient T cells were retrovirally transduced with TR or CD25− TCRα genes in MigR1-MG (without IRES-GFP), or “empty” vector MigR1. Two days later, 4 × 105 T cells were adoptively transferred into RAG1-deficient hosts for 11 days. The percentage of transduced T cells in the population adoptively transferred was normalized to a fixed value (between 3% and 6%) using concurrently activated nontransduced TCli αβ-TCR × RAG1-deficient transgenic T cells. Expansion of T cells expressing transduced TCRs (the percentage of Vα2+ or GFP+ cells within the Vβ6+ CD4+ T cell population, top) and the total percentage of transferred T cells in the spleen (% Vβ6+ CD4+, middle) was assessed by flow cytometry. Bottom panels show representative FACS plots of the graphed data. Two independent experiments are shown. Each symbol represents relative cell expansion in a single recipient. (B) CD25+ TCR recognition of self peptide:MHC class II complexes is required for in vivo expansion. TCli αβ-TCR × RAG1-deficient T cells were retrovirally transduced as above. Two days later, 4 × 105 T cells were adoptively transferred into TCRα-deficient or TCRα × Ii × H-2M triple-deficient hosts for 12 days before assessment of expansion of transduced T cells in the spleen by flow cytometry as the percentage of Vα2+ or GFP+ cells within the total transferred CD4+ Vβ6+ T cell population. The percentage of transduced T cells in the adoptively transferred population was normalized to 2.33% or 5% using concurrently activated nontransduced TCli αβ-TCR × RAG1-deficient T cells. Immunity 2004 21, 267-277DOI: (10.1016/j.immuni.2004.07.009)

Figure 5 A High Frequency of Individual TR, but Not CD25−, TCRs Recognize Self Peptide:MHC Class II Complexes with Increased Avidity TCRs used in Figure 4 were individually tested using the same approach. Because some of these TCRs were poorly recognized by the Vα2 antibody, an additional CD25+ and 3 additional CD25− TCRs were also analyzed to make a group of 10 individual TCRs tested for each subset (Supplemental Table S1). The plots summarize data from eight different experiments, with each symbol representing data from a single recipient. In every experiment, T cells transduced with the pool of CD25+ TCRs were used as the positive control and with “empty” vector as the negative control. To normalize the expansion of transduced T cells between experiments, we used the following formula: relative expansion = (% experimental − % “empty” vector)/(% CD25+ pool − % “empty” vector). Thus, expansion equivalent to the pool of 10 CD25+ TCRs would give a value of 1, and no expansion a value of 0. The dashed line at 0.2 represents the upper limit of variability found in the “empty” vector controls. Application of the nonparametric Wilcoxon Rank Sum Test to the mean relative expansion for each TCR demonstrates that the differences observed between the groups of CD25+ and CD25− TCRs tested are statistically significant (p ≤ 0.009). Immunity 2004 21, 267-277DOI: (10.1016/j.immuni.2004.07.009)

Figure 6 Skewing of CD25+ T Cell Development by TCR Specificity (A) Analysis of CD25+ and CD25− CD4+ T cell subsets in bone marrow chimeras expressing retrovirally transduced TCRα clones S19 and N11. The CD25+-derived clone S19, but not the CD25−-derived clone N11, was found to confer in vivo self-reactivity in experiments similar to those shown in Figure 4 (data not shown). These TCRα genes were retrovirally transduced into TCli TCR-β bone marrow and adoptively transferred to lethally irradiated RAG1-deficient mice as previously described (Gough and Raines, 2003). After 6 weeks, expression of CD25, GFP, and Vα2 was assessed by flow cytometry of axillary and inguinal lymph node cells. Cells analyzed were gated for CD4 expression. T cells expressing the retroviral TRAV14 TCRα gene co-express GFP present in the MigR1 vector. Similar results were obtained by flow cytometric analysis of splenocytes from chimeric mice (data not shown). (B) Analysis of CD25+ and CD25− CD4+ T cell subsets in bone marrow chimeras expressing retrovirally transduced TCRα clones R5, G113, B2, and B8. The self-reactive CD25+-derived TCRα clones R5 and G113 and the non-self-reactive CD25−-derived TCRα clones B2 and B8 (Figure 5) were individually transduced into TCli-β transgenic bone marrow as above. The percentage of CD25 expressing retrovirally transduced Vα2+ GFP+ CD4+ T cells from the axillary and inguinal lymph nodes 6 weeks after bone marrow reconstitution is shown (±SEM). Data are pooled from two independent experiments (R5 n = 6, G113 n = 3, B2 n = 5, B8 n = 2). Immunity 2004 21, 267-277DOI: (10.1016/j.immuni.2004.07.009)